Tuberculosis and HIV: latest news

Tuberculosis and HIV resources

Tuberculosis and HIV features

Tuberculosis and HIV in your own words

Tuberculosis and HIV news from aidsmap

More news

Tuberculosis and HIV news selected from other sources

  • HIV patients should be included in early clinical trials of anti-TB drugs

    Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide, yet the majority of these patients are excluded from the early stages in the development of new, anti-tuberculosis drugs, according to research.

    01 October 2015 | Science Daily
  • Big Price Increase for TB Drug Is Rescinded

    A huge overnight price increase for an important tuberculosis drug has been rescinded after the company that acquired the drug gave it back to its previous owner under pressure, it was announced on Monday.

    22 September 2015 | New York Times
  • WHO Sounds Alarm Over Big Indian Supplier Of Tuberculosis Drugs

    A major Indian supplier of tuberculosis drugs to developing countries has been severely criticized by the World Health Organization for inadequate manufacturing standards and poor testing procedures.

    09 September 2015 | Medical Daily
  • Anti-smoking Strategies Critical to TB and HIV Care

    A new study calls for urgent action to integrate anti-smoking strategies into the care of people being treated for tuberculosis and HIV.

    28 August 2015 | VOA News
  • Multidrug-resistant TB appears less transmissible in households than drug-susceptible TB

    Some strains of multidrug-resistant tuberculosis (MDRTB) may have a lower fitness (be less capable of spreading) than drug-susceptible tuberculosis bacteria, according to a study published this week in PLOS Medicine.

    24 June 2015 | Eurekalert Inf Dis
  • Large-scale study underscores value of routine Xpert testing on TB, MDR TB case finding

    A study of more than 100,000 patients with suspected tuberculosis at 18 sites across India showed that routine testing using Xpert molecular technology rather than the most commonly used — and oldest — diagnostic tool of examining a sputum smear under a microscope, increased detection of TB by 39 percent and led to five times the rate of detecting resistance to a TB treatment medicine.

    28 May 2015 | Science Speaks
  • Dust, TB and HIV: the ugly face of mining in South Africa

    Two of the greatest philanthropic organisations in the world, responsible for saving countless lives through scientific research and healthcare programmes, are heavily invested in fossil fuel industries that have profound impacts on the health of local communities and cause climate change. Nowhere is this paradox more acute than in South Africa, a country with the biggest HIV caseload in the world and an economy founded on mining.

    26 May 2015 | The Guardian
  • End stigmatizing language in tuberculosis research and practice

    Traditional terms invoke metaphors of transgression and punishment rather than of dignity and cure. Phrases such as “treatment defaulter” and “initial defaulter” apply the moral judgment of loan nonpayment to describe patients who stop treatment or never start it. Other phrases, such as “tuberculosis suspect,” treat patients as if they had committed a crime.

    07 April 2015 | EATG / BMJ
  • Ukraine: Concurrent treatment for HIV/TB co-infection breaks up “deadly alliance”

    USAID funded MEASURE Evaluation to initiate an impact evaluation in Ukraine for two TB programmatic priorities: Improving integration of TB and HIV services to reduce mortality through early diagnosis and treatment for co-infected patients; and providing social support services to improve TB treatment adherence.

    30 March 2015 | Science Speaks
  • Final fight pays off, XXDR-TB & HIV patient cured

    Once an active case of extremely drug resistant (XXDR-TB) strain of tuberculosis or totally drug resistant (TDR) TB, 40-year-old Rashid Khan (name changed), has now been completely cured of his disease. Despite having total drug resistance and HIV infection, Khan got cured a few days ago. At one stage he was receiving a cocktail of 18–20 drugs between his HIV and TB regimes. But Bedaquiline made a huge difference in his treatment. He is off medicine now.

    24 March 2015 | DNAIndia
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.